* Achieve Life Sciences Inc ACHV.OQ reported a quarterly
adjusted loss of 26 cents per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -83 cents. The mean expectation of
seven analysts for the quarter was for a loss of 31 cents per
share. Wall Street expected results to range from -35 cents
to -28 cents per share.
* Reported revenue was zero; analysts expected zero.
* Achieve Life Sciences Inc's reported EPS for the quarter
was a
loss of 26 cents.
* The company reported a quarterly loss of $5.48 million.
* Achieve Life Sciences Inc shares had risen by 9.7% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 0.8%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Achieve
Life
Sciences Inc is $18.00
This summary was machine generated from LSEG data March 28 at
09:02 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.31 -0.26 Beat
Sep. 30 2023 -0.38 -0.34 Beat
Jun. 30 2023 -0.42 -0.43 Missed
Mar. 31 2023 -0.69 -0.50 Beat